Rare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network Study

OBJECTIVE: Fenofibrate, a peroxisome proliferator-activated receptor-alpha (PPARα) agonist, reduces triglyceride (TG) concentrations by 25–60%. Given significant inter-individual variation in TG response, we investigated the association of PPARA rare variants with treatment response in the Genetics...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Irvin, Marguerite R, Zhang, Qunyuan, Kabagambe, Edmond K, Perry, Rodney T, Straka, Robert J., Tiwari, Hemant K, Borecki, Ingrid B, Shimmin, Lawrence C., Stuart, Colin, Zhong, Yu, Hixson, James E, Arnett, Donna K
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3325369/
https://ncbi.nlm.nih.gov/pubmed/22336959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e328351a486
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg